A Study of BPI-452080 in Subjects With Solid Tumors

Clinical trial NCT05843305 · UNKNOWN

Trial details

NCT number: NCT05843305
Sponsor: Betta Pharmaceuticals Co., Ltd.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Solid Tumor Renal Cell Carcinoma Von Hippel-Lindau Disease

Start date: 2023-04-28
Primary completion: 2025-03-25
Enrollment: 87

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.